🇺🇸 FDA
Patent

US 9744132

Solid solution compositions and use in chronic inflammation

granted A61KA61K31/12A61K31/137

Quick answer

US patent 9744132 (Solid solution compositions and use in chronic inflammation) held by Infirst Healthcare Limited expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Infirst Healthcare Limited
Grant date
Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/12, A61K31/137, A61K31/167, A61K31/19